Inventor · disambiguated record
Thomas M. Barnes
Also filed as: BARNES THOMAS · BARNES THOMAS M · BARNES THOMAS MALCOLM · BARNES THOMAS MICHAEL
22 granted patents·35 pending applications·85 citations·filing 1977–2023
94Inventor score
Files withMILLENNIUM PHARM INC16ORNA THERAPEUTICS INC10ELEVEN BIOTHERAPEUTICS INC5BARNES THOMAS M3BIOENTERPRISES PTY LIMITED2
Top patents by PatentIndex Score
57 records- 0189US10711050B2Variant serum albumin with improved half-life and other propertiesALBUMEDIX LTD·Filed 2018·Granted Jul 14, 2020·6 cites·33 claims
- 0287US4105439AMethod for production of refined steelHARSCO CORP·Filed 1977·Granted Aug 8, 1978·14 cites·11 claims
- 0386US12415776B2Lipid nanoparticle compositions for delivering circular polynucleotidesORNA THERAPEUTICS INC·Filed 2023·Granted Sep 16, 2025·0 cites·28 claims
- 0486US12384741B2Lipid nanoparticle compositions for delivering circular polynucleotidesORNA THERAPEUTICS INC·Filed 2023·Granted Aug 12, 2025·0 cites·28 claims
- 0586US12180138B2Lipid nanoparticle compositions for delivering circular polynucleotidesORNA THERAPEUTICS INC·Filed 2023·Granted Dec 31, 2024·0 cites·28 claims
- 0686US12077485B2Lipid nanoparticle compositions for delivering circular polynucleotidesORNA THERAPEUTICS INC·Filed 2023·Granted Sep 3, 2024·0 cites·28 claims
- 0782US9951130B2IL-6 antagonists and uses thereofELEVEN BIOTHERAPEUTICS INC·Filed 2014·Granted Apr 24, 2018·7 cites·20 claims
- 0881US6764677B1Tango 294, a lipase-like proteinMILLENNIUM PHARM INC·Filed 2000·Granted Jul 20, 2004·5 cites·20 claims
- 0980US7842709B2Method for treating inflammatory diseases of the digestive tractORE PHARMACEUTICALS INC·Filed 2007·Granted Nov 30, 2010·8 cites·19 claims
- 1074US8853150B2Chimeric IL-1 receptor type I antagonistsBARNES THOMAS M·Filed 2011·Granted Oct 7, 2014·5 cites·115 claims
- 1172US12297285B2Circular RNA encoding chimeric antigen receptors targeting BCMAORNA THERAPEUTICS INC·Filed 2022·Granted May 13, 2025·0 cites·32 claims
- 1270US8003334B2Methods for identifying compounds which bind to TANGO294MILLENNIUM PHARM INC·Filed 2009·Granted Aug 23, 2011·0 cites·4 claims
- 1370US2025376534A1Circular rna encoding chimeric antigen receptors targeting bcmaORNA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1466US7547766B2Anti-tango294 antibodies and uses thereofMILLENNIUM PHARM INC·Filed 2003·Granted Jun 16, 2009·0 cites·7 claims
- 1565US5645121AMethod of continuous casting using sealed tundish and improved tundish sealNAT STEEL CORP·Filed 1996·Granted Jul 8, 1997·13 cites·9 claims
- 1665US2009136959A1Novel genes encoding proteins having prognostic, diagnostic preventive, therapeutic, and other usesMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 1764US2009220977A1Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other usesMILLENNIUM PHARM INC·Filed 2009·Application pending·0 cites
- 1863US7033780B1Nucleic acids corresponding to TANGO 294 a gene encoding a lipase—like proteinMILLENNIUM PHARM INC·Filed 1999·Granted Apr 25, 2006·9 cites·14 claims
- 1962US2025268828A1Lipid Nanoparticle Compositions for Delivering Circular PolynucleotidesORNA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2059US2025283073A1Circular RNA Compositions and MethodsORNA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2158US2004019917A1NEOKINE protein and nucleic acid molecules and uses thereforMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 2257US11459386B2IL-6 antagonists and uses thereofELEVEN BIOTHERAPEUTICS INC·Filed 2018·Granted Oct 4, 2022·0 cites·10 claims
- 2357US2006122373A1Delta3, FTHMA-070, Tango85, Tango77, SPOIL,NEOKINE, Tango129 and integrin alpha subunit protein and nucleic acid molecules and uses thereofMILLENNIUM PHARM INC·Filed 2005·Application pending·0 cites
- 2456US9458216B2Nucleic acid encoding chimeric IL-1 receptor type I antagonistsELEVEN BIOTHERAPEUTICS INC·Filed 2014·Granted Oct 4, 2016·0 cites·29 claims
- 2556US2006205034A1Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other usesMILLENNIUM PHARM INC·Filed 2005·Application pending·0 cites
- 2656US2008213778A1Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other usesMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 2755US2014072968A1Novel Genes Encoding Proteins Having Prognostic, Diagnostic, Preventive, Therapeutic, and Other UsesDANA FARBER CANCER INST INC·Filed 2013·Application pending·0 cites
- 2855US2007031439A1Novel protein related to melanoma-inhibiting protein and uses thereofMILLENNIUM PHARM INC·Filed 2006·Application pending·0 cites
- 2954US2023226096A1Circular rna compositions and methodsORNA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3054US2002166133A1Neokine protein and nucleic acid molecules and uses thereforMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 3154US2009186014A1Method for treatment of pancreatitisORE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3253US6949378B1C. elegans gro-1 geneUNIV MCGILL·Filed 2000·Granted Sep 27, 2005·1 cites·8 claims
- 3353US2024042015A1Circular rna compositions and methodsORNA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3452US2010291579A1Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other usesMILLENNIUM PHARM INC·Filed 2010·Application pending·0 cites
- 3552US2003022279A1Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other usesFiled 2001·Application pending·0 cites
- 3650US2003224451A1Novel protein related to melanoma-inhibiting protein and uses thereofMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 3750US2012270219A1Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other usesHOLTZMAN DOUGLAS A·Filed 2012·Application pending·0 cites
- 3849US2012045777A1Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other usesFRASER CHRISTOPHER C·Filed 2011·Application pending·0 cites
- 3947US2014315817A1Variant serum albumin with improved half-life and other propertiesELEVEN BIOTHERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 4046US2002103360A1Novel protein related to melanoma-inhibiting protein and uses thereofFiled 2001·Application pending·0 cites
- 4146US2002182675A1Novel genes encoding proteins having diagnostic, preventive, therapeutic and other usesMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 4246US2016052993A1Albumin variants binding to fcrnELEVEN BIOTHERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4344US5976839AImmunopotentiation through covalent linkage between immunogen and immunopotentiating moleculesBIOENTERPRISES PTY LIMITED·Filed 1995·Granted Nov 2, 1999·5 cites·18 claims
- 4444US2006141575A1Secreted proteins and nucleic acids encoding themMILLENNIUM PHARM INC·Filed 2006·Application pending·0 cites
- 4543US2008234345A1Method for reducing or alleviating inflammation in the digestive tractGENE LOGIC INC·Filed 2007·Application pending·0 cites
- 4641US5422090AHuman PAI-2BIOTECH AUSTRALIA PTY LTD·Filed 1992·Granted Jun 6, 1995·12 cites·20 claims
- 4741US2012009183A1Method for treatment of pancreatitisTARTAGLIA LOUIS ANTHONY·Filed 2011·Application pending·0 cites
- 4841US2003027998A1Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other usesFiled 2001·Application pending·0 cites
- 4941US2018112234A9Methods and compositions for gene editingINTELLIA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 5041US2010035848A1Therapy for disorders of the proximal digestive tractDONAHUE STEPHEN RICHARD·Filed 2009·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Thomas M. Barnes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →